| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 75961 |
DOTA-4Py 螯合剂DOTA偶联吡啶基4Py |
71 |
h |
2024-12-19 |
| 75962 |
钆喷酸葡胺(Gd-BOPTA) |
199 |
h |
2024-12-19 |
| 75963 |
DOTA-SA-mAb |
77 |
h |
2024-12-19 |
| 75964 |
(LLP2A-DOTA)(4)PEG(10000) |
73 |
h |
2024-12-19 |
| 75965 |
LLP2A-DOTA-聚乙二醇 LLP2A-DOTA-PEG |
69 |
h |
2024-12-19 |
| 75966 |
DOTA-AaLS/HER2Afb HER2Afb修饰DOTA缀合的AaLS-ST |
85 |
h |
2024-12-19 |
| 75967 |
DOTA-P4 Thz-Phe-D-Trp-Lys-Thr-DOTA DOTA的线型超短肽缀合物 |
98 |
h |
2024-12-19 |
| 75968 |
DOTA-BP DOTA偶联双膦酸盐 |
120 |
h |
2024-12-19 |
| 75969 |
DOTA缀合的p160肽基放射缀合物 DOTA-p160 |
99 |
h |
2024-12-19 |
| 75970 |
DOTA-氮氧化合物 DOTA-NOx |
85 |
h |
2024-12-19 |
| 75971 |
Er-DOTA 铒-DOTA配合物 |
91 |
h |
2024-12-19 |
| 75972 |
DOTA-SETSKSF DOTA偶联七个氨基酸残基组成的环肽抑制剂 |
133 |
h |
2024-12-19 |
| 75973 |
羧基Bn-DOTA p-COOH-Bn-DOTA |
82 |
h |
2024-12-19 |
| 75974 |
DOTA四酰肼钆(ⅲ)配合物 |
85 |
h |
2024-12-19 |
| 75975 |
3-Gd(III)-氨基乙基酰胺基-DOTA的缀合物 |
109 |
h |
2024-12-19 |
| 75976 |
TCO功能化的CC49抗体 TCO-CC49 |
187 |
h |
2024-12-19 |
| 75977 |
CLT1肽靶向Gd(III)螯合物 CLT1-dL-(Gd-DOTA) |
112 |
h |
2024-12-19 |
| 75978 |
DOTA-pNO(2)-Phe-c(DCys-Tyr-DTrp-Lys-Thr-Cys)DTyrNH |
126 |
h |
2024-12-19 |
| 75979 |
Gd-DOTA-PLGA-b-PEG 钆-四氮杂环十二烷四乙酸共轭的聚(乳酸-共-乙醇酸)-嵌段-聚(乙二醇)共聚物胶束 |
119 |
h |
2024-12-19 |
| 75980 |
DOTA聚乙二醇化星形共聚物纳米粒子 |
89 |
h |
2024-12-19 |
| 75981 |
镓-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-Leu-Thr-Val-Ser-Pro-Trp-Tyr |
116 |
h |
2024-12-19 |
| 75982 |
DOTA-C595 p-SCN-Bn-DOTA偶联C595抗体 |
142 |
h |
2024-12-19 |
| 75983 |
DOTA-Tyr3-奥曲肽 DOTA-Tyr3-TOC |
87 |
h |
2024-12-19 |
| 75984 |
DOTA-生物素-亲和素 DOTA-biotin-avidin |
62 |
h |
2024-12-19 |
| 75985 |
DOTA-AuNPs 螯合剂DOTA包覆金纳米颗粒 |
99 |
h |
2024-12-19 |
| 75986 |
PS-WSCS-DOTA-BBN 水溶性壳聚糖缀合的DOTA-铃蟾肽包覆的金纳米颗粒 |
79 |
h |
2024-12-19 |
| 75987 |
苄基DOTA Bn-DOTA |
193 |
h |
2024-12-19 |
| 75988 |
DOTA-LM3 生长抑素受体(SSTR)拮抗剂 |
103 |
h |
2024-12-19 |
| 75989 |
Ga-DOTA-MGS5 大环配体-靶向肽 |
99 |
h |
2024-12-19 |
| 75990 |
Re-cyc-DOTA-sst2-ANT复合物 |
98 |
h |
2024-12-19 |
| 75991 |
DOTA-SP DOTA-P物质(SP) |
107 |
h |
2024-12-19 |
| 75992 |
DOTA-MG45 DOTA偶联迷你胃泌素(MG45) |
105 |
h |
2024-12-19 |
| 75993 |
DOTA-甘露糖胺葡聚糖 DOTA-MADs |
85 |
h |
2024-12-19 |
| 75994 |
ICG-DOTA 大环配体DOTA修饰吲哚菁绿荧光染料 |
103 |
h |
2024-12-18 |
| 75995 |
DOTA-SSA 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)-生长抑素类似物(SSA) |
84 |
h |
2024-12-18 |
| 75996 |
DOTA螯合剂修饰[cPP(1-7) |
143 |
h |
2024-12-18 |
| 75997 |
DOTA-ALB-24 DOTA-4-(对碘苯基)丁酸酯-24 |
94 |
h |
2024-12-18 |
| 75998 |
DOTA-GGNle-CycMSH hex DOTA偶联新肽 |
112 |
h |
2024-12-18 |
| 75999 |
Zr-p-NO2Bn-DOTA异构体 锆-硝基苄基偶联DOTA螯合剂 |
106 |
h |
2024-12-18 |
| 76000 |
DOTA-PSMA-617 1,4,7,10-四氮杂环十五烷偶联PSMA-617 |
83 |
h |
2024-12-18 |
| 76001 |
DOTA-VAP-1 螯合剂DOTA偶联VAP-1靶向肽 |
146 |
h |
2024-12-18 |
| 76002 |
DOTA-GIP-C803 DOTA螯合剂缀合GIPC803肽 |
75 |
h |
2024-12-18 |
| 76003 |
DOTA-mPS 螯合剂DOTA修饰微米级聚苯乙烯 |
105 |
h |
2024-12-18 |
| 76004 |
DOTA-HBED-bisphosphonate DOTA-HBED-二膦酸盐 |
102 |
h |
2024-12-18 |
| 76005 |
CAS号：2226472-28-0 ，DBCO-PEG4-Val-Cit-PAB-PNP |
105 |
WYQ |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询